Marriott Stock Up as Q3 Earnings Beat Estimates, RevPAR Rises Y/Y — Positive

MAR   Zacks Investment Research — November 04, 2025

MAR's third-quarter earnings and revenues beat estimates as strong global demand and luxury segment gains lift results.

image for news Marriott Stock Up as Q3 Earnings Beat Estimates, RevPAR Rises Y/Y

Norwegian Q3 Earnings Beat, Revenues Miss Estimates, Stock Down — Positive

NCLH   Zacks Investment Research — November 04, 2025

NCLH beat third-quarter earnings estimates but missed on revenues, with shares sinking 9% despite record occupancy and strong demand.

image for news Norwegian Q3 Earnings Beat, Revenues Miss Estimates, Stock Down

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) (“uniQure”). On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational gene therapy for Huntington's disease, did not provide sufficient evidence to support uniQure's Biologics Licen.

image for news NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action.

image for news Law Offices of Frank R. Cruz Encourages James Hardie Industries plc (JHX) Shareholders To Inquire About Securities Fraud Class Action

Norway wealth fund to oppose Elon Musk's $1T Tesla pay package — Negative

TSLA   Proactive Investors — November 04, 2025

Norway's sovereign wealth fund announced on Tuesday that it will vote against Tesla Inc (NASDAQ:TSLA) CEO Elon Musk's proposed compensation package at the company's annual shareholder meeting on November 6. The package is contingent on Tesla achieving ambitious milestones over the next decade, including growing the company's market value to $8.5 trillion.

image for news Norway wealth fund to oppose Elon Musk's $1T Tesla pay package

Gold, silver down as USDX hits 6-mo. high — Negative

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  SIL  SILJ  SIVR  SLV  SLVP  UGL   Kitco — November 04, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold, silver down as USDX hits 6-mo. high

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In WPP To Contact Him Directly To Discuss Their Options

image for news WPP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of WPP

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fly-E Group, Inc. (NASDAQ: FLYE) between July 15, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline.

image for news FLYE DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Fly-E Group, Inc. Investors to Secure Counsel Before Important November 10 Deadline in Securities Class Action – FLYE

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Marex To Contact Him Directly To Discuss Their Options

image for news MRX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group

Investors Still Lovin' McDonald's? Bull Case Perspective Into MCD Earnings — Positive

MCD   Schwab Network — November 04, 2025

McDonald's (MCD) will offer a clearer picture not just for the state of the company, but also for the fast-food industry. Brian Szytel believes the set-up looks good heading into the report as it mitigates labor woes.

image for news Investors Still Lovin' McDonald's? Bull Case Perspective Into MCD Earnings

INOD Stock Ahead of Q3 Earnings: Time to Add or Stay Cautious? — Neutral

INOD   Zacks Investment Research — November 04, 2025

Innodata to post third-quarter results on Nov. 6, with strong AI-driven revenue momentum but margin pressure from growth investments.

image for news INOD Stock Ahead of Q3 Earnings: Time to Add or Stay Cautious?

Take-Two to Report Q2 Earnings: What's in the Cards for the Stock? — Positive

TTWO   Zacks Investment Research — November 04, 2025

TTWO is poised for strong fiscal Q2 results with blockbuster game launches like NBA 2K26 and Borderlands, which are expected to drive bookings growth.

image for news Take-Two to Report Q2 Earnings: What's in the Cards for the Stock?

My bull case revolves around the 2 GW Sweetwater hub, which could expand GPU capacity by 30x, while the $9.7B Microsoft deal drives momentum in the AI cloud segment. Microsoft prepays 20% (~$2B) on a 5-year contract. In exchange, IREN will buy $5.8B of Dell systems, adding 200 MW at Childress through 2026. Funding is tight. The $1B ATM program is already depleted. The $1B raised in convertible notes, plus Microsoft's $2B prepayment, still leaves a $1.8B gap to meet the Dell commitment.

image for news IREN Limited: $9.7B Microsoft Catalyst, But I Remain Cautious Into Q1 On Dilution Risk

LAS VEGAS and ITASCA, Ill. , Nov. 4, 2025 /PRNewswire/ -- Boxabl Inc. ("BOXABL"), a leader in innovative housing solutions, and FG Merger II Corp. ("FGMC") (Nasdaq: FGMC), a publicly traded special purpose acquisition company, today announced that they have signed an amendment (the "Amendment") to their previously announced Agreement and Plan of Merger (the "Merger Agreement") for a merger between the two companies.

image for news BOXABL and FG Merger II Corp. Extend Outside Date for Completion of Proposed Merger

Federated Hermes: Staying Bullish With Q3 Outperformance And Latest M&A — Positive

FHI   Seeking Alpha — November 04, 2025

Federated Hermes's 3Q25 top-line and bottom-line beat the consensus forecasts by +5% and +20%, respectively. FHI's acquisition of FCP Fund Manager broadens its U.S. real estate presence, boosts diversification efforts, and is expected to be margin-accretive. The 4Q2025 outlook for FHI remains positive, considering management's disclosures regarding a robust pipeline.

image for news Federated Hermes: Staying Bullish With Q3 Outperformance And Latest M&A

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fly-E Group, Inc. (“Fly-E” or “the Company”) (NASDAQ: FLYE) and certain of its officers.

image for news FLYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fly-E Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) and certain of its officers.

image for news DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today's obesity treatment landscape Preclinical and clinical data demonstrates the potential of ARD-201 to attenuate weight gain, promote weight loss and help maintain weight after the discontinuation of GLP-1RA Aardvark to host investor webinar on November 5th, 2025 to review ARD-101 and ARD-201 programs, as well as ObesityWeek presentations SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to …

image for news Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members currently or previously on GLP-1 medications for weight loss. Together, these analyses suggest that engagement with Omada may enhance results for members who have been on GLP-1s for weight loss, whether they stay on the medication or not.

image for news Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users

Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference — Neutral

CHE   GlobeNewsWire — November 04, 2025

CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.

image for news Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference